@inproceedings{inproceedings, title = {{Can an annual infusion of zoledronic acid protect against cancer-treatment induced bone loss (CTIBL)?}}, url = {{}}, year = {{2005}}, month = {{6}}, author = {{Brown JE and Lester J and Ellis S and Gutcher S and Turner L and Purohit OP and Hancock B and Coleman R}}, volume = {{23}}, journal = {{JOURNAL OF CLINICAL ONCOLOGY}}, issue = {{16}}, pages = {{734S-734S}}, note = {{Accessed on 2025/04/17}}}